STAT July 16, 2020
Covid-19 has depleted stockpiles of essential medicines in the U.S., straining our supply chains and hobbling the treatment of critically ill patients. The government and pharmaceutical companies are already decades late in trying to fix this problem and so far their proposed solutions fall short. To prepare for the next crisis — and make no mistake, there will be a next crisis — we need an entirely new way to make lifesaving medicines.
Two technologies — synthetic biology and fermentation — offer a promising alternative to traditional manufacturing.
Supply chain failures are leading to unnecessary suffering. In May, the FDA reported shortages of drugs including paralytics, which are needed to safely and painlessly insert breathing tubes, and analgesics, which manage...
Today's Sponsors
Today's Sponsor